Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection

Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection

Show other versions (1)
Bibliographic Details
Main Authors: Heidi J. Wehring, Sheryl Thedford, Maju Koola, Deanna L. Kelly
Format: Article
Language:English
Published: SAGE Publishing 2011-06-01
Series:Journal of Central Nervous System Disease
Online Access:http://www.la-press.com/patient-and-health-care-provider-perspectives-on-long-acting-injectabl-a2693
id doaj-47d98ca7f5b345079ef830ea95ca085f
record_format Article
spelling doaj-47d98ca7f5b345079ef830ea95ca085f2020-11-25T03:17:50ZengSAGE PublishingJournal of Central Nervous System Disease1179-57352011-06-0120113107123Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting InjectionHeidi J. WehringSheryl ThedfordMaju KoolaDeanna L. Kellyhttp://www.la-press.com/patient-and-health-care-provider-perspectives-on-long-acting-injectabl-a2693
collection DOAJ
language English
format Article
sources DOAJ
author Heidi J. Wehring
Sheryl Thedford
Maju Koola
Deanna L. Kelly
spellingShingle Heidi J. Wehring
Sheryl Thedford
Maju Koola
Deanna L. Kelly
Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
Journal of Central Nervous System Disease
author_facet Heidi J. Wehring
Sheryl Thedford
Maju Koola
Deanna L. Kelly
author_sort Heidi J. Wehring
title Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
title_short Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
title_full Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
title_fullStr Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
title_full_unstemmed Patient and Health Care Provider Perspectives on Long Acting Injectable Antipsychotics in Schizophrenia and the Introduction of Olanzapine Long-Acting Injection
title_sort patient and health care provider perspectives on long acting injectable antipsychotics in schizophrenia and the introduction of olanzapine long-acting injection
publisher SAGE Publishing
series Journal of Central Nervous System Disease
issn 1179-5735
publishDate 2011-06-01
url http://www.la-press.com/patient-and-health-care-provider-perspectives-on-long-acting-injectabl-a2693
work_keys_str_mv AT heidijwehring patientandhealthcareproviderperspectivesonlongactinginjectableantipsychoticsinschizophreniaandtheintroductionofolanzapinelongactinginjection
AT sherylthedford patientandhealthcareproviderperspectivesonlongactinginjectableantipsychoticsinschizophreniaandtheintroductionofolanzapinelongactinginjection
AT majukoola patientandhealthcareproviderperspectivesonlongactinginjectableantipsychoticsinschizophreniaandtheintroductionofolanzapinelongactinginjection
AT deannalkelly patientandhealthcareproviderperspectivesonlongactinginjectableantipsychoticsinschizophreniaandtheintroductionofolanzapinelongactinginjection
_version_ 1724629665374535680

Similar Items